UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

Use of the HLA-B leader to optimize cord blood transplantation

Haematologica (Roma), 2021-12, Vol.106 (12), p.3107

2021

Volltextzugriff (PDF)

Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research

Frontiers in cell and developmental biology, 2022-08, Vol.10, p.979306-979306

2022

Volltextzugriff (PDF)

Cord Blood Platelet Rich Plasma Derivatives for Clinical Applications in Non-transfusion Medicine

Frontiers in immunology, 2020-05, Vol.11, p.942-942

2020

Volltextzugriff (PDF)

Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties

Scientific reports, 2021-07, Vol.11 (1), p.13754-13754, Article 13754

2021

Volltextzugriff (PDF)

Recycling Apparent Waste Into Biologicals: The Case of Umbilical Cord Blood in Italy and Spain

Frontiers in cell and developmental biology, 2022-01, Vol.9, p.812038-812038

2022

Volltextzugriff (PDF)

Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow Donor Association Cord Blood Working Group

Stem cells translational medicine, 2021-02, Vol.10 (2), p.222-229

2021

Volltextzugriff (PDF)

Rationale for combined therapies in severe-to-critical COVID-19 patients

Frontiers in immunology, 2023-09, Vol.14, p.1232472-1232472

2023

Volltextzugriff (PDF)

Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells

PloS one, 2014-01, Vol.9 (1), p.e87086-e87086

2014

Volltextzugriff (PDF)

Rapid review: next generation of cord blood banks; transplantation and beyond

Transfusion (Philadelphia, Pa.), 2019-10, Vol.59 (10), p.3048-3050

2019

Volltextzugriff (PDF)

Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model

PloS one, 2015-10, Vol.10 (10), p.e0138623-e0138623

2015

Volltextzugriff (PDF)

Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis

Transfusion (Philadelphia, Pa.), 2016-08, Vol.56 (8), p.2021-2029

2016

Volltextzugriff (PDF)

Cord blood Lin(-)CD45(-) embryonic-like stem cells are a heterogeneous population that lack self-renewal capacity

PloS one, 2013-06, Vol.8 (6), p.e67968-e67968

2013

Volltextzugriff (PDF)

The wider perspective: cord blood banks and their future prospects

British journal of haematology, 2021-11, Vol.195 (4), p.507-517

2021

Volltextzugriff (PDF)

Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?

Haematologica (Roma), 2009-04, Vol.94 (4), p.536-541

2009

Volltextzugriff (PDF)

The Assessment of Parameters Affecting the Quality of Cord Blood by the Appliance of the Annexin V Staining Method and Correlation with CFU Assays

Stem Cells International, 2013-01, Vol.2013, p.823912-10

2013

Volltextzugriff (PDF)

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage

Bone marrow transplantation (Basingstoke), 2020-10, Vol.55 (10), p.2043-2044

2020

Volltextzugriff (PDF)

CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report

The lancet HIV, 2015-06, Vol.2 (6), p.e236-e242

2015

Volltextzugriff (PDF)

The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation

Human immunology, 2012-03, Vol.73 (3), p.248-257

2012

Volltextzugriff (PDF)

Cord blood banking: current status

Hematology (Luxembourg), 2012-04, Vol.17 (sup1), p.s185-s188

Querol, Sergio

2012

Volltextzugriff (PDF)

Viral-Specific T Cell Therapy for Cytomegalovirus Infection after Stem Cell Transplantation and Generation of a Third-Party T-Cell Donor Registry

Blood, 2022-11, Vol.140 (Supplement 1), p.10309-10310

2022

Volltextzugriff (PDF)

Abstract 7: Influence of Long-term Storage of Cryopreserved Automated Volume-Reduced Cord Blood Units Until 20 Years: Analysis From Barcelona Cord Blood Bank, Spain

Stem cells translational medicine, 2024-08, Vol.13 (Suppl 1), p.S8-S8

2024

Volltextzugriff (PDF)

A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studies

Clinical proteomics, 2011-09, Vol.8 (1), p.14-14, Article 14

2011

Volltextzugriff (PDF)

Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?

Bone marrow transplantation (Basingstoke), 2024-08, Vol.59 (8), p.1206-1206

2024

Volltextzugriff (PDF)

Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols

British journal of haematology, 2016-02, Vol.172 (3), p.360-370

2016

Volltextzugriff (PDF)

Clinical evaluation of allogeneic eye drops from cord blood platelet lysate

Blood transfusion = Trasfusione del sangue, 2021-07, Vol.19 (4), p.347-356

2021

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(133)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Use of the HLA-B leader to optimize cord blood transplantation

Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research

Cord Blood Platelet Rich Plasma Derivatives for Clinical Applications in Non-transfusion Medicine

Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties

Recycling Apparent Waste Into Biologicals: The Case of Umbilical Cord Blood in Italy and Spain

Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow Donor Association Cord Blood Working Group

Rationale for combined therapies in severe-to-critical COVID-19 patients

Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells

Rapid review: next generation of cord blood banks; transplantation and beyond

Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model

Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis

Cord blood Lin(-)CD45(-) embryonic-like stem cells are a heterogeneous population that lack self-renewal capacity

The wider perspective: cord blood banks and their future prospects

Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?

The Assessment of Parameters Affecting the Quality of Cord Blood by the Appliance of the Annexin V Staining Method and Correlation with CFU Assays

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage

CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report

The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation

Cord blood banking: current status

Viral-Specific T Cell Therapy for Cytomegalovirus Infection after Stem Cell Transplantation and Generation of a Third-Party T-Cell Donor Registry

Abstract 7: Influence of Long-term Storage of Cryopreserved Automated Volume-Reduced Cord Blood Units Until 20 Years: Analysis From Barcelona Cord Blood Bank, Spain

A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studies

Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?

Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols

Clinical evaluation of allogeneic eye drops from cord blood platelet lysate

Suchergebnisse filtern